2020 Conference on Retroviruses and Opportunistic Infections*

March 8-11, 2020; Boston, Massachusetts
Get up to date on the latest HIV data with rapid Capsule Summaries, video highlights, downloadable slidesets, on-demand audio, and expert analysis covering key studies from Boston.

European Perspectives

Capsule Summary Slidesets

HIV diagnoses in France declined between 2013 and 2018, corresponding with introduction of universal ART provision in 2013 and large-scale PrEP rollout in 2016.

Released: March 15, 2020

Updated analysis of 2016 continuum of HIV care found that 11 mostly Western European countries are on track to meet UNAIDS 90-90-90 goal

Released: March 15, 2020

Community viremia and HIV incidence both significantly decreased from 2012-2017 among gay and bisexual men in Australia.

Released: March 18, 2020

Low prevalence of transmitted ARV resistance and clinically relevant resistance to recommended first-line ARVs observed in cohort of ART-naive PWH in Spain.

Released: March 18, 2020

Analysis of the EuResist database reveals prevalence and predictors of resistance to all 4 main ARV drug classes in treatment-experienced patients in Europe.

Released: March 15, 2020

Reduced inpatient and outpatient visits observed following SVR with oral HCV DAA therapy in real-world HIV/HCV-coinfected population.

Released: March 17, 2020

HCV incidence in MSM with HIV in France declined from 2014 to 2017 following unrestricted access of HCV DAA therapy for persons with HIV.

Released: March 17, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue